Dr. Tseng Chih-Jen discussed liquid biopsy, CTC testing, and how blood-based information may complement standard clinical assessment.
Dr. Tseng Chih-Jen of Chung Shan Medical University Hospital joined Famous Doctor On Call to discuss liquid biopsy and circulating tumor cells.
The conversation covered the biological basis of CTCs, specimen processing, and the potential role of blood-based information in cancer-related assessment and follow-up.
Liquid biopsy and CTC testing are adjunct tools. They do not replace imaging, pathology, or diagnosis by a qualified physician.
Good Future concluded four days of discussions and demonstrations at the 2025 Healthcare+ Expo Taiwan, welcoming healthcare professionals and visitors from Taiwan and Southeast Asia.
Good Future and Inventec Appliances presented Chiline CATCH, Family Pal, and TTSmart at Medical Fair Asia 2024 in Singapore.
Good Future and Wellspring are developing a partnership in Malaysia focused on professional training, market development, and healthcare collaboration.